These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29773702)

  • 1. Exploring variation in human papillomavirus vaccination uptake in Switzerland: a multilevel spatial analysis of a national vaccination coverage survey.
    Riesen M; Konstantinoudis G; Lang P; Low N; Hatz C; Maeusezahl M; Spaar A; Bühlmann M; Spycher BD; Althaus CL
    BMJ Open; 2018 May; 8(5):e021006. PubMed ID: 29773702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling the consequences of regional heterogeneity in human papillomavirus (HPV) vaccination uptake on transmission in Switzerland.
    Riesen M; Garcia V; Low N; Althaus CL
    Vaccine; 2017 Dec; 35(52):7312-7321. PubMed ID: 29126806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Policy and socio-cultural differences between cantons in Switzerland with high and low adolescent vaccination coverage for hepatitis B and HPV.
    Masserey Spicher V; Weiss MG
    Vaccine; 2019 Dec; 37(52):7539-7546. PubMed ID: 31630937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007-2016.
    Gallagher KE; Howard N; Kabakama S; Mounier-Jack S; Burchett HED; LaMontagne DS; Watson-Jones D
    Papillomavirus Res; 2017 Dec; 4():72-78. PubMed ID: 29179873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community-based household assessment of human papillomavirus (HPV) vaccination coverage and acceptability - HPV vaccine demonstration program, Cambodia - 2017.
    Garon J; Wuddhika IV; Sreenivasan N; Wannemuehler K; Vutthikol Y; Chhorvann C; Loharikar A
    Vaccine; 2019 Feb; 37(9):1202-1208. PubMed ID: 30686637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.
    Msyamboza KP; Mwagomba BM; Valle M; Chiumia H; Phiri T
    BMC Public Health; 2017 Jun; 17(1):599. PubMed ID: 28651574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Social determinants of community-level human papillomavirus vaccination coverage in aschool-based vaccination programme.
    Jean S; Elshafei M; Buttenheim A
    Sex Transm Infect; 2018 Jun; 94(4):248-253. PubMed ID: 29330310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of school-entry and education mandates by states on HPV vaccination coverage: Analysis of the 2009-2013 National Immunization Survey-Teen.
    Perkins RB; Lin M; Wallington SF; Hanchate AD
    Hum Vaccin Immunother; 2016 Jun; 12(6):1615-22. PubMed ID: 27152418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus vaccination coverage, policies, and practical implementation across Europe.
    Nguyen-Huu NH; Thilly N; Derrough T; Sdona E; Claudot F; Pulcini C; Agrinier N;
    Vaccine; 2020 Feb; 38(6):1315-1331. PubMed ID: 31836255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Factors associated with HPV immunization for 13-14-year-old girls in the Geneva district, Switzerland].
    Jeannot E; Wyler CA; Meynard A; Kaiser B; Sudre P; Alvarin J; Chastonay P
    Rev Epidemiol Sante Publique; 2013 Dec; 61(6):513-8. PubMed ID: 24206904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing uptake of HPV vaccination among girls in Germany.
    Schülein S; Taylor KJ; König J; Claus M; Blettner M; Klug SJ
    BMC Public Health; 2016 Sep; 16():995. PubMed ID: 27645711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus vaccine uptake in boys and girls in a school-based vaccine delivery program in Prince Edward Island, Canada.
    McClure CA; MacSwain MA; Morrison H; Sanford CJ
    Vaccine; 2015 Apr; 33(15):1786-90. PubMed ID: 25731789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination coverage rates and predictors of HPV vaccination among eligible and non-eligible female adolescents at the Brazilian HPV vaccination public program.
    Faisal-Cury A; Levy RB; Tourinho MF; Grangeiro A; Eluf-Neto J
    BMC Public Health; 2020 Apr; 20(1):458. PubMed ID: 32252705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus vaccination coverage in Luxembourg - Implications of lowering and restricting target age groups.
    Latsuzbaia A; Arbyn M; Weyers S; Mossong J
    Vaccine; 2018 Apr; 36(18):2411-2416. PubMed ID: 29602702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Virginia's School-Entry Vaccine Mandate on Human Papillomavirus Vaccination Among 13-17-Year-Old Females.
    Pierre-Victor D; Page TF; Trepka MJ; Stephens DP; Li T; Madhivanan P
    J Womens Health (Larchmt); 2017 Mar; 26(3):266-275. PubMed ID: 27697003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus vaccine coverage in Rwanda: A population-level analysis by birth cohort.
    Sayinzoga F; Umulisa MC; Sibomana H; Tenet V; Baussano I; Clifford GM
    Vaccine; 2020 May; 38(24):4001-4005. PubMed ID: 32336599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in Human Papillomavirus Vaccination in Commercially Insured Children in the United States.
    Chen ST; Huybrechts KF; Bateman BT; Hernández-Díaz S
    Pediatrics; 2020 Oct; 146(4):. PubMed ID: 32928985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus (HPV) vaccination coverage in Brazil: spatial and age cohort heterogeneity.
    Moura LL; Codeço CT; Luz PM
    Rev Bras Epidemiol; 2020; 24():e210001. PubMed ID: 33331411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends and factors associated with receipt of human papillomavirus (HPV) vaccine in private, public, and alternative settings in the United States.
    White MC; Osazuwa-Peters OL; Abouelella DK; Barnes JM; Cannon TY; Watts TL; Adjei Boakye E; Osazuwa-Peters N
    Vaccine; 2024 Sep; 42(22):126036. PubMed ID: 38876838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can physicians and schools mitigate social inequalities in human papillomavirus vaccine awareness, uptake and vaccination intention among adolescents? A cross-sectional study, France, 2021 to 2022.
    Moffroid H; Doglioni DO; Chyderiotis S; Sicsic J; Barret AS; Raude J; Bruel S; Gauchet A; Michel M; Gagneux-Brunon A; Thilly N; Mueller JE;
    Euro Surveill; 2023 Nov; 28(46):. PubMed ID: 37971661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.